Vitamin B3 for sepsis patients in intensive care
Treatments studied
Part of Infections clinical trials.
This trial tests whether adding oral nicotinamide (a type of vitamin B3) to standard sepsis treatment helps patients recover faster. It is for adults in the intensive care unit who have sepsis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently in the intensive care unit (ICU).
- You have been diagnosed with sepsis, a serious infection that can cause organ damage.
- You are not pregnant or breastfeeding.
- You are not allergic to nicotinamide (a form of vitamin B3).
- You are not already taking antioxidant supplements like vitamin C or vitamin E.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if taking a vitamin B3 supplement (nicotinamide) can improve outcomes for people with rheumatoid arthritis. Researchers want to see if adding this over-the-counter vitamin to your usual arthritis medicines helps reduce disease activity.
This trial tests whether a combination of vitamins B6, B12, and C can help improve blood flow in tiny blood vessels (microcirculation) for people with sepsis. It may help your body recover better from severe infection.
This study tests whether a special form of vitamin D can improve outcomes for patients with sepsis, a severe infection that can cause organ failure. The treatment is given to patients in the intensive care unit, and the study aims to see if it helps them recover better.
This study tests whether giving a vitamin B3 supplement (nicotinamide) before, during, and after heart surgery can help protect the kidneys from injury. If you are having heart surgery and have a higher risk of kidney damage, this treatment might reduce that risk.
This trial tests an experimental drug called NAI for people in the intensive care unit (ICU) with severe infections like sepsis. It aims to boost your immune system to help fight the infection and improve recovery.
This study tests whether a daily supplement called nicotinamide riboside (a form of vitamin B3) can help people with moderate chronic kidney disease. It aims to see if the supplement improves kidney function or slows down the disease.
Hear when a new Sepsis - to Reduce Mortality in the Intensive Care Unit trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.